PCWT Awesome Penny Stocks Pacific Clean Water Technologies

New Post Public Reply Private Reply Replies (0) Message Board
Rosner

Awesome Penny Stocks' new "pick", Pacific Clean Water Technologies ( PCWT ) , released just a day after PWEI was halted, didn't quite have the grand day you might think, unless you owned it last night.  The average share traded today was bought at $.16619 and gained only 7%. Furthermore volume was was down fromo the typical volumes seen by APS "picks" on the first day. Today's PCWT dollar volume was $15 million, while PWEI 's dollar volume on its first day as APS' "pick" was $37 million. There is definitely more investor caution with this "pick" than other APS "picks" especially since OTCmarkets slapped a Caveat Emptor Status on this ticker just minutes after its announcement.  Many are now concerned that PCWT could see the same fate that PWEI did, just days after it was announced as the APS "pick". The similarities between the two tickers run deep, especially the Coldicutt family connection we pointed out in last night's advisory which warned subscribers to stay far away from this ticker.

FDMF continued its 5 week old course due south, all the while under promotion. Shares are now down 62% from last month's launch of the Pump & Dump campaign.

Likewise for AXXE , another ridiculous Pump & Dump that seems to keep finding volunteers to become bag holders.  These shares are now down 51% from its launch price and today featured an overpay* rate of 94%. While it has dropped from 90 cents to 44 cents, it still has a lot of room to go further south, and we suspect that like IALS before it, AXXE will get promoted all the way down to the single digit pennies.

OCTX which opened today at 3.27 times book value sported a mostly losing trades today, at an overpay rate of 98%.  While the book value is high for an OTC stock, the valuation of the stock is insane and shares have a long way to drop to approach that book value.  Expect it to get promoted all the way down to more reasonible levels as well.

Promoted Tickers Closing With A Majority of Overpays*

ARTT  AXXE  FDMF  NVLX  OCTX

Promoted Tickers Closing Below The Promotion Launch Price

ARTT  AXXE  BLDW  CETC  FDMF  OCTX  USRC

Promoted Tickers Whose High Trade Occurred Before 10:00am

ARTT  AXXE  BLDW  CETC  FDMF  NVLX  OCTX  PCWT  USRC

Promoted Tickers That Closed Down From Previous Day's Close

AXXE  BLDW  CETC  FDMF  NVLX  OCTX

Promoted Tickers On A Two Day Down Trend

ARTT  BLDW

Promoted Tickers On A Three Day Down Trend

FDMF  NVLX

Promoted Tickers On At Least A Four Day Down Trend

none

See the details on The Nightly

* trades at prices higher than the stock's closing price

The Nightly is published every evening after the market closes and is an analytical chart of the trading in stocks which have been promoted that day.

We continue to present PumpsandDumps.com as a free public service.  We do not short stocks.  Never have.  Never will.  Anybody who says otherwise is just a liar.  Period.

Be careful out there!

www.pumpsanddumps.com

Content Copyright 2011-2013 pumpsanddumps.com . All Rights Reserved.

The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: PumpsAndDumps.com is a free public service and never shorts stocks. PumpsAndDumps.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. The opinions expressed here are the property of PumpsAndDumps.com and are for information purposes only. Nothing found on this website should be considered as an advisement to buy or sell any stock. PumpsAndDumps.com receives no compensation for any of the information posted on this website.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading